Paul Emery
- Rheumatology top 0.5%
- Hematology top 2%
- Genetics top 2%
- Immunology top 10%
- Pathology and Forensic Medicine top 10%
- Co-authors
- Gerd R BurmesterDiane CorscaddenPeter V. GiannoudisIppokratis PountosEdward KeystoneBernard CombeDaniel E. FurstT. Huizinga
- Topics
- Rheumatoid Arthritis Research and Therapies (45 papers)Chronic Lymphocytic Leukemia Research (19 papers)Systemic Lupus Erythematosus Research (15 papers)
- Cited by
- RheumatologyHematologyGenetics
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Paul Emery
56 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 100
- Rheumatology 1.1k
- Hematology 405
- Genetics 363
- Immunology 333
- Pathology and Forensic Medicine 214
Countries citing papers authored by Paul Emery
This map shows the geographic impact of Paul Emery's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Emery with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Emery more than expected).
Fields of papers citing papers by Paul Emery
This network shows the impact of papers produced by Paul Emery. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Emery. The network helps show where Paul Emery may publish in the future.
Co-authorship network of co-authors of Paul Emery
This figure shows the co-authorship network connecting the top 25 collaborators of Paul Emery. A scholar is included among the top collaborators of Paul Emery based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Emery. Paul Emery is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 8 | |
| 4 | 37 | |
| 5 | 1 | |
| 6 | 1 | |
| 7 | 19 | |
| 8 | Stringent Criteria for Low Disease Activity and Remission after 12 Months of Treatment, and after Treatment Withdrawal, with Abatacept Monotherapy, Abatacept with Methotrexate or Methotrexate Alone in Early Rheumatoid Arthritis | 4 |
| 9 | 70 | |
| 10 | 86 | |
| 11 | The Efficacy of Certolizumab Pegol Added to Methotrexate is Sustained Over 2 Years in the Treatment of Rheumatoid Arthritis | 8 |
| 12 | 207 | |
| 13 | Clinical remission, radiographic non-progression, and normalized function with the combination of etanercept and methotrexate in the treatment of early active rheumatoid arthritis: 1-year results of the COMET trial | 1 |
| 14 | 92 | |
| 15 | Remission rates in subjects with active early rheumatoid arthritis 1 year results of the COMET trial: Combination of methotrexate and etanercept in active early rheumatoid arthritis | 5 |
| 16 | 144 | |
| 17 | 10 | |
| 18 | 4 | |
| 19 | 21 | |
| 20 | 25 |
About Paul Emery
Paul Emery is a scholar working on Rheumatology, Genetics and Hematology, having authored 64 papers that have together received 1.7k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (45 papers), Chronic Lymphocytic Leukemia Research (19 papers) and Systemic Lupus Erythematosus Research (15 papers). The work is most often cited by research in Rheumatology (1.1k citations), Hematology (405 citations) and Genetics (363 citations). Paul Emery has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Gerd R Burmester, Diane Corscadden, Peter V. Giannoudis, Ippokratis Pountos, Edward Keystone, Bernard Combe, Daniel E. Furst, T. Huizinga, Benazir Saleem and Clifton O. Bingham. Their work appears in journals such as Annals of the Rheumatic Diseases, Lara D. Veeken and Journal of Nuclear Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.